Home › Companies › AnaptysBio, Inc. › 2024-2025

AnaptysBio, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and AnaptysBio, Inc.’s Form 8-K, filed June 17, 2025 (Item 5.07 on EDGAR). Page generated October 25, 2026.

  • 7Reported items
  • 184Asset managers
  • 1,422Fund votes
  • June 17, 2025Meeting date

Results at a glance

Meeting of June 17, 2025: 6 items on AnaptysBio, Inc.’s Form 8-K, filed June 17, 2025: 6 without a stated outcome.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025

Explore AnaptysBio, Inc. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by AnaptysBio, Inc.

These tallies are AnaptysBio, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

AnaptysBio, Inc. — official shareholder meeting results, meeting held June 17, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Rita Jain, M.D. 23,913,554---- 1,763,0971,589,342 93%Not verified—
Elect Director: John Orwin 21,616,016---- 4,060,6351,589,342 84%Not verified—
Elect Director: J. Anthony Ware, M.D. 21,035,965---- 4,640,6861,589,342 82%Not verified—
2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 27,248,16617,021806 ---- 99.9%Not verified—
3. Non-binding, advisory approval of compensation paid to the Company's named executive officers 17,781,5456,590,1931,304,913 --1,589,342 73%Not verified—
4. Approval of the amendment and restatement of the Company's 2017 Equity Incentive Plan 18,017,1436,354,7181,304,790 --1,589,342 74%Not verified—

Source: AnaptysBio, Inc., Form 8-K, filed with the SEC on June 17, 2025 — read the filing on EDGAR.

How asset managers voted at the AnaptysBio, Inc. 2024-2025 meeting

Each item below shows how the 184 asset managers that disclosed a AnaptysBio, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of AnaptysBio, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: J. Anthony Ware, M.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%WITHHELD
FOR: 21,035,965WITHHELD: 4,640,686
Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: J. Anthony Ware, M.D.

AnaptysBio, Inc.’s own tally for this item (“Elect Director: J. Anthony Ware, M.D.”): 21,035,965 for, 4,640,686 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 1,746,056 for, 1,183,352 withheld.

FORWITHHOLD
FOR: 1,746,056WITHHOLD: 1,183,352
Largest asset managers voting on “To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockhol” at AnaptysBio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock554,3580 00For
T. Rowe Price495,1110 00For
Victory Capital00 0393,769Withhold
Vanguard246,4360 0400For
Bridge Builder Trust4,1800 0237,430Withhold
Fidelity20,9560 0169,648Mixed
Charles Schwab154,2900 00For
State Street131,6140 0170For
FRANKLIN STRATEGIC SERIES00 0128,979Withhold
TIAA95,9680 00For
Delaware/Macquarie00 093,732Withhold
Equitable3,8580 030,320Mixed
Jackson National00 033,320Withhold
Northern Trust00 018,214Withhold
Lincoln Financial15,6000 00For
ProShares00 011,284Withhold
AIG/SunAmerica00 011,042Withhold
Federated Hermes7,9130 00For
ETFis Series Trust I00 07,490Withhold
ALPS ETF Trust00 07,427Withhold
Pacific Life7,2290 00For
Brighthouse00 06,034Withhold
Direxion Shares ETF Trust00 05,485Withhold
MASTER INVESTMENT PORTFOLIO5,0880 00For
John Hancock00 04,424Withhold

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

2. Elect Director: John Orwin

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD
FOR: 21,616,016WITHHELD: 4,060,635
Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: John Orwin

AnaptysBio, Inc.’s own tally for this item (“Elect Director: John Orwin”): 21,616,016 for, 4,060,635 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 1,905,216 for, 1,024,192 withheld.

FORWITHHOLD
FOR: 1,905,216WITHHOLD: 1,024,192
Largest asset managers voting on “To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockhol” at AnaptysBio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock554,3580 00For
T. Rowe Price495,1110 00For
Victory Capital00 0393,769Withhold
Vanguard246,4360 0400For
Bridge Builder Trust4,1800 0237,430Withhold
Fidelity20,9560 0169,648Mixed
Charles Schwab154,2900 00For
State Street131,6140 0170For
FRANKLIN STRATEGIC SERIES128,9790 00For
TIAA95,9680 00For
Delaware/Macquarie00 093,732Withhold
Equitable3,8580 030,320Mixed
Jackson National00 033,320Withhold
Northern Trust18,2140 00For
Lincoln Financial15,6000 00For
ProShares00 011,284Withhold
AIG/SunAmerica00 011,042Withhold
Federated Hermes7,9130 00For
ETFis Series Trust I00 07,490Withhold
ALPS ETF Trust00 07,427Withhold
Pacific Life7,2290 00For
Brighthouse00 06,034Withhold
Direxion Shares ETF Trust00 05,485Withhold
MASTER INVESTMENT PORTFOLIO5,0880 00For
John Hancock00 04,424Withhold

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

3. Elect Director: Rita Jain, M.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 23,913,554WITHHELD: 1,763,097
Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Rita Jain, M.D.

AnaptysBio, Inc.’s own tally for this item (“Elect Director: Rita Jain, M.D.”): 23,913,554 for, 1,763,097 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 2,145,495 for, 783,913 withheld.

FORWITHHOLD
FOR: 2,145,495WITHHOLD: 783,913
Largest asset managers voting on “To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockhol” at AnaptysBio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,1100 0553,248Withhold
T. Rowe Price495,1110 00For
Victory Capital393,7690 00For
Vanguard246,8360 00For
Bridge Builder Trust237,4300 04,180For
Fidelity13,8270 0176,777Mixed
Charles Schwab154,2900 00For
State Street131,7840 00For
FRANKLIN STRATEGIC SERIES128,9790 00For
TIAA95,9680 00For
Delaware/Macquarie93,7320 00For
Equitable00 034,178Withhold
Jackson National33,3200 00For
Northern Trust18,2140 00For
Lincoln Financial15,6000 00For
ProShares11,2840 00For
AIG/SunAmerica11,0420 00For
Federated Hermes00 07,913Withhold
ETFis Series Trust I7,4900 00For
ALPS ETF Trust7,4270 00For
Pacific Life00 07,229Withhold
Brighthouse6,0340 00For
Direxion Shares ETF Trust5,4850 00For
MASTER INVESTMENT PORTFOLIO5,0880 00For
John Hancock4,4240 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

4. 4. Approval of the amendment and restatement of the Company's 2017 Equity Incentive Plan

Outcome not verifiedFund totals may overlapCOMPENSATIONReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%AGAINST
FOR: 18,017,143AGAINST: 6,354,718
Details: description as filed, official tally, votes by 51 asset managers

Description as filed by funds: TO APPROVE AN AMENDMENT TO OUR 2017 EQUITY INCENTIVE PLAN.

AnaptysBio, Inc.’s own tally for this item (“4. Approval of the amendment and restatement of the Company's 2017 Equity Incentive Plan”): 18,017,143 for, 6,354,718 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 74% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 47 asset managers voting on “TO APPROVE AN AMENDMENT TO OUR 2017 EQUITY INCENTIVE PLAN.” at AnaptysBio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock554,3580 00For
T. Rowe Price0495,111 00Against
Victory Capital0393,769 00Against
Vanguard0246,836 00Against
Bridge Builder Trust4,180237,430 00Against
Fidelity7,629182,975 00Against
Charles Schwab0154,290 00Against
State Street313131,471 00Against
FRANKLIN STRATEGIC SERIES0128,979 00Against
TIAA095,968 00Against
Delaware/Macquarie093,732 00Against
Equitable3,85830,320 00Mixed
Jackson National033,320 00Against
Northern Trust018,214 00Against
Lincoln Financial015,600 00Against
ProShares011,284 00Against
AIG/SunAmerica011,042 00Against
Federated Hermes07,913 00Against
ETFis Series Trust I07,490 00Against
ALPS ETF Trust07,427 00Against
Pacific Life7,2290 00For
Brighthouse06,034 00Against
Direxion Shares ETF Trust05,485 00Against
MASTER INVESTMENT PORTFOLIO5,0880 00For
John Hancock04,424 00Against

Fund voting reports, all 47 managers: 582,697 for, 2,346,711 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 3 asset managers voting on “TO APPROVE AN AMENDMENT TO OUR 2017 EQUITY INCENTIVE PLAN.” at AnaptysBio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
EcoR1 Capital, LLC7,880,0940 00For
First Light Asset Management, LLC4,111,7310 00For
UNITED CAPITAL FINANCIAL ADVISORS, LLC02,709 00Against

Institutional-manager reports, all 3 managers: 11,991,825 for, 2,709 against.

5. 3. Non-binding, advisory approval of compensation paid to the Company's named executive officers

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 7 wordings of this item as funds reported it.

73% Majority: yes · of votes cast

FOR 73%AGAINST
FOR: 17,781,545AGAINST: 6,590,193
Details: description as filed, official tally, votes by 183 asset managers

Description as filed by funds: To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials.

AnaptysBio, Inc.’s own tally for this item (“3. Non-binding, advisory approval of compensation paid to the Company's named executive officers”): 17,781,545 for, 6,590,193 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 73% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 48 asset managers voting on “To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the” at AnaptysBio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,110553,248 00Against
T. Rowe Price0495,111 00Against
Victory Capital0393,769 00Against
Vanguard246,436400 00For
Bridge Builder Trust0241,610 00Against
Fidelity0190,604 00Against
Charles Schwab0154,290 00Against
State Street131,442342 00For
FRANKLIN STRATEGIC SERIES0128,979 00Against
TIAA095,968 00Against
Delaware/Macquarie093,732 00Against
Equitable034,178 00Against
Jackson National033,320 00Against
Northern Trust18,2140 00For
Lincoln Financial15,6000 00For
ProShares011,284 00Against
AIG/SunAmerica011,042 00Against
FORUM FUNDS II08,150 00Against
Federated Hermes07,913 00Against
ETFis Series Trust I07,490 00Against
ALPS ETF Trust07,427 00Against
Pacific Life07,229 00Against
Brighthouse06,034 00Against
Direxion Shares ETF Trust05,485 00Against
MASTER INVESTMENT PORTFOLIO5,0880 00For

Fund voting reports, all 48 managers: 419,297 for, 2,518,261 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 149 asset managers voting on “To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the” at AnaptysBio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
EcoR1 Capital, LLC7,880,0940 00For
First Light Asset Management, LLC4,111,7310 00For
Point721,719,7460 00For
Sofinnova Investments, Inc.0813,516 00Against
Palo Alto Investors LP00 00--
Woodline Partners LP760,7700 00For
Camber Capital Management LP0750,000 00Against
T. Rowe Price0718,426 00Against
Victory Capital0651,085 00Against
BlackRock96,329454,093 00Mixed
Fidelity0537,165 00Against
5AM Venture Management, LLC357,7330 00For
FRANKLIN ADVISERS INC0354,370 00Against
State Street332,4382,179 00For
Madison Avenue Partners, LP291,7880 00For
Ensign Peak Advisors, Inc215,4540 00For
Citadel179,0350 00For
Charles Schwab0154,290 00Against
Northern Trust114,4704,299 00For
Opaleye Management Inc.98,6740 00For
Exome Asset Management LLC97,6960 00For
Nuveen096,998 00Against
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST093,732 00Against
Renaissance091,475 00Against
Allianz090,945 00Against

Institutional-manager reports, all 149 managers: 16,414,117 for, 5,490,571 against, 806,346 unknown, 6,028 1 year. Showing the 25 largest; see all in the interactive database.

6. Non-binding advisory vote on the frequency of holding future advisory votes regarding named executive officer…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

99.8% Fund and manager reports combined; may count the same shares twice · no official result

FOR1 YEAR
Details: description as filed, votes by 170 asset managers

Description as filed by funds: Non-binding advisory vote on the frequency of holding future advisory votes regarding named executive officer compensation.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 47 asset managers voting on “Non-binding advisory vote on the frequency of holding future advisory votes regarding named executive officer ” at AnaptysBio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock00 00--
T. Rowe Price00 00--
Victory Capital00 00--
Vanguard00 00--
Bridge Builder Trust00 00--
Fidelity00 00--
Charles Schwab00 00--
State Street00 00--
FRANKLIN STRATEGIC SERIES00 00--
TIAA00 00--
Delaware/Macquarie00 00--
Equitable00 00--
Jackson National00 00--
Northern Trust00 00--
Lincoln Financial00 00--
ProShares00 00--
AIG/SunAmerica00 00--
Federated Hermes00 00--
ETFis Series Trust I00 00--
ALPS ETF Trust00 00--
Pacific Life00 00--
Brighthouse00 00--
Direxion Shares ETF Trust00 00--
MASTER INVESTMENT PORTFOLIO00 00--
John Hancock00 00--

Fund voting reports, all 47 managers: 2,929,408 1 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 139 asset managers voting on “Non-binding advisory vote on the frequency of holding future advisory votes regarding named executive officer ” at AnaptysBio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
First Light Asset Management, LLC4,111,7310 00For
Point7200 00--
Sofinnova Investments, Inc.00 00--
Palo Alto Investors LP00 00--
Woodline Partners LP00 00--
Camber Capital Management LP00 00--
T. Rowe Price00 00--
Victory Capital00 00--
BlackRock00 00--
Fidelity00 00--
5AM Venture Management, LLC00 00--
FRANKLIN ADVISERS INC00 00--
State Street00 00--
Madison Avenue Partners, LP00 00--
Ensign Peak Advisors, Inc00 00--
Citadel00 00--
Charles Schwab00 00--
Northern Trust00 00--
Nuveen00 00--
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST00 00--
Renaissance00 00--
Allianz00 00--
DE Shaw00 00--
UBS00 00--
Wellington00 00--

Institutional-manager reports, all 139 managers: 4,112,951 for, 6,159 against, 9,384,923 1 year, 806,346 unknown, 218,289 3 year. Showing the 25 largest; see all in the interactive database.

7. 2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 27,248,166AGAINST: 17,021
Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

AnaptysBio, Inc.’s own tally for this item (“2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 27,248,166 for, 17,021 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 2,929,054 for, 354 against.

FOR
FOR: 2,929,054AGAINST: 354
Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR” at AnaptysBio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock554,3580 00For
T. Rowe Price495,1110 00For
Victory Capital393,7690 00For
Vanguard246,8360 00For
Bridge Builder Trust241,6100 00For
Fidelity190,6040 00For
Charles Schwab154,2900 00For
State Street131,7768 00For
FRANKLIN STRATEGIC SERIES128,9790 00For
TIAA95,9680 00For
Delaware/Macquarie93,7320 00For
Equitable34,1780 00For
Jackson National33,3200 00For
Northern Trust18,2140 00For
Lincoln Financial15,6000 00For
ProShares11,2840 00For
AIG/SunAmerica11,0420 00For
Federated Hermes7,9130 00For
ETFis Series Trust I7,4900 00For
ALPS ETF Trust7,4270 00For
Pacific Life7,2290 00For
Brighthouse6,0340 00For
Direxion Shares ETF Trust5,4850 00For
MASTER INVESTMENT PORTFOLIO5,0880 00For
John Hancock4,4240 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

Largest AnaptysBio, Inc. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 30,387,893 shares outstanding at the time of that meeting.

Fund voting reports: top AnaptysBio, Inc. shareholders by shares voted on “To conduct a non-binding advisory vote on the compensation of our named executive officers as…”, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 1.82%
2T. Rowe Price 1.63%
3Victory Capital 1.30%
4Vanguard 0.81%
5Bridge Builder Trust 0.80%
6Fidelity 0.63%
7Charles Schwab 0.51%
8State Street 0.43%
9FRANKLIN STRATEGIC SERIES 0.42%
10TIAA 0.32%
Institutional-manager reports: top AnaptysBio, Inc. shareholders by shares voted on “To conduct a non-binding advisory vote on the compensation of our named executive officers as…”, 2024-2025
#Asset manager % of shares outstanding
1EcoR1 Capital, LLC 25.93%
2First Light Asset Management, LLC 13.53%
3Point72 5.66%
4Sofinnova Investments, Inc. 2.68%
5Palo Alto Investors LP 2.65%
6Woodline Partners LP 2.50%
7Camber Capital Management LP 2.47%
8T. Rowe Price 2.36%
9Victory Capital 2.14%
10BlackRock 1.81%

Reported AnaptysBio, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

AnaptysBio, Inc. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
EcoR1 Capital LLC 25.93% DEF14A
Oleg Nodelman 25.93% DEF14A
First Light Asset Management, LLC 15.31% 13G
FMR LLC 9.45% DEF14A
Point72 7.79% 13F
BlackRock 7.16% 13F
FMR (Fidelity) 6.27% 13F
Point72 Asset Management, L.P. 5.57% DEF14A
James N. Topper 5.45% 13G
Vanguard Group 4.99% 13F

Percentages above are of 30,387,893 shares outstanding, as reported by AnaptysBio, Inc. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AnaptysBio, Inc.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.

At AnaptysBio, Inc.'s shareholder meeting held June 17, 2025, in the 2024-2025 proxy season, 184 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,422 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To conduct a non-binding advisory vote on the compensation of our named executive officers as… — FOR was 73% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AnaptysBio, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 17, 2025.

AnaptysBio, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page).

Download data (CSV): ballot items · votes by manager · column guide.